Josh Mandel-Brehm

CAMP

Josh Mandel-Brehm serves as director, officer: Chief Executive Officer at CAMP4 Therapeutics Corporation (CAMP). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$10.8K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$10.8K

Companies Traded

CAMP

Active Period

Aug 2026

1 total trades

Most Recent

Buy CAMP

Aug 5, 2026 · $10.8K

Josh Mandel-Brehm's Insider Trading at CAMP4 Therapeutics Corporation (CAMP)

Buys

1 · $10.8K

Sells

0 · $0.00

Total Shares Bought

6,551

Total Shares Sold

CAMP Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 5, 2026	Buy	6,551	$1.65	$10.8K	284,968

Related Insiders

Kelly Gold

officer: Chief Financial Officer

CAMPBuy · Sep 2, 2026

Andrew J. Schwab

director

CAMPSell · Aug 31, 2026

Daniel Tardiff

officer: Chief Scientific Officer

CAMPSell · Aug 19, 2026

Yuri Maricich

officer: Chief Medical Officer

CAMPBuy · Aug 5, 2026

Richard A Young

director

CAMPBuy · Aug 5, 2026

Explore More Insider Trading Data

CAMP Insider Trading Activity

View all insider trades at CAMP4 Therapeutics Corporation

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity